Delivery Order SPE2DB22D3016-SPE2DB24FALT8
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,974.92 contract is for the provision of "REFRESH PLUS 0.5% EYE DROPS 30S" pharmaceutical products. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables Amerisourcebergen Drug Corp to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,857.20 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S," a pharmaceutical product, with a period of performance through May 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REFRESH PLUS 0.5% EYE DROPS UD 70S. The delivery order, with a potential value of $1,368.90, has a completion date of February 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and does not have any set-aside designation for this contract. This delivery...
- The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $3,217.25 to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S". This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, serving as the primary mechanism for the company to provide a wide range of pharmaceutical products...
- The Defense Logistics Agency awarded a $1,588.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops UD 70s, with a completion date of December 31, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order represents a small-value transaction within the company's broader federal pharmaceutical supply portfolio and aligns with the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply REFRESH PLUS 0.5% EYE DROPS UD 70S. The contract has a ceiling value of $1,196.48 and a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not part of a set-aside program. Additionally, Amerisourcebergen Drug Corp holds an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,361.54 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price contract with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $5,853.66 firm fixed price delivery order is for the supply of "Refresh Plus 0.5% Eye Drops 30S" to support military treatment programs and facilities. The contract has an ultimate completion date of March 26, 2024 and does not utilize any set-aside designations....
- The Defense Logistics Agency awarded a $643.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the refreshment of eye drops. Under this contract, Amerisourcebergen will provide approximately 30 bottles of Refresh Plus 0.5% eye drops to meet requirements at a facility located in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen routinely supports procurement initiatives managed by the...
- The Defense Logistics Agency (DLA) awarded a $1,719.02 delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (70 unit dose vials) on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs,...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FALT8Delivery Order
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, a firm fixed price delivery order contract valued at $1,743.03 for the provision of "REFRESH PLUS 0.5% EYE DROPS 30S" pharmaceutical products. This order falls under a larger, single award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designations have been used for this contract. Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, has received numerous federal contract awards from DLA to support military treatment programs and facilities with a range of critical medical products and related services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 2/8/24 |